Minyi Zhao
Overview
Explore the profile of Minyi Zhao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
301
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Ma Q, Zhao M, Long B, Li H
Commun Biol
. 2023 Jun;
6(1):622.
PMID: 37296281
Acute myeloid leukemia is the most common acute leukemia in adults, the barrier of refractory and drug resistance has yet to be conquered in the clinical. Abnormal gene expression and...
12.
Yu Y, Meng Y, Xu X, Tong T, He C, Wang L, et al.
ACS Nano
. 2023 Feb;
17(4):3334-3345.
PMID: 36752654
Ferroptosis is an alternative strategy to overcome chemoresistance, but effective therapeutic approaches to induce ferroptosis for acute myeloid leukemia (AML) treatment are limited. Here, we developed glutathione (GSH)-responsive cysteine polymer-based...
13.
Xu X, Zhang W, Xuan L, Yu Y, Zheng W, Tao F, et al.
Nat Cell Biol
. 2023 Jan;
25(1):170-182.
PMID: 36624186
T cell acute lymphoblastic leukaemia (T-ALL) is an aggressive malignancy with poor prognosis, but a decisive marker and effective treatment for leukaemia stem cells (LSCs) remain unclear. Here, using lineage...
14.
Zhao J, Zhao F, Yang T, Tian S, Zhao M, Wang S, et al.
Environ Toxicol
. 2021 Dec;
37(4):695-707.
PMID: 34931434
Family with sequence similarity 83, member A (FAM83A) is a tumor-exclusive gene that has a vital role in numerous tumors. However, its role in tumorigenesis remains controversial. This work is...
15.
Zhang W, Ma Q, Long B, Sun Z, Liu L, Lin D, et al.
Front Oncol
. 2021 Nov;
11:725336.
PMID: 34722267
Acute myeloid leukemia (AML) is an aggressive hematological malignancy with high relapse/refractory rate. Genetic and epigenetic abnormalities are driving factors for leukemogenesis. RUNX1 and RUNX2 from the Runt-related transcription factor...
16.
Liu J, Zhao M, Feng X, Zeng Y, Lin D
Aging (Albany NY)
. 2021 May;
13(10):14088-14108.
PMID: 33999861
Caspase1 (CASP1) is a gene that encodes multiple proteins related to cell death. Nevertheless, the function of CASP1 in the pathogenesis of AML is still unclear. In the present study,...
17.
Lou Q, Zhao M, Xu Q, Xie S, Liang Y, Chen J, et al.
Front Cell Dev Biol
. 2021 Apr;
9:658757.
PMID: 33889575
Bone marrow mesenchymal stem/stromal cells (BMSCs) can be transformed into tumor-associated MSCs (TA-MSCs) within the tumor microenvironment to facilitate tumor progression. However, the underline mechanism and potential therapeutic strategy remain...
18.
Li T, Qing Tang B, Zhang W, Zhao M, Hu Q, Ahn A
Evid Based Complement Alternat Med
. 2021 Apr;
2021:5581227.
PMID: 33854554
The anatomical basis of acupuncture meridians continues to be enigmatic. Although much attention has been placed on potential correlations with inter/intramuscular fascia or lower electrical impedance, animal studies performed in...
19.
Yuan C, Wu M, Xiao Q, Zhao W, Li H, Zhong Y, et al.
Signal Transduct Target Ther
. 2021 Feb;
6(1):92.
PMID: 33640898
No abstract available.
20.
Evaluation of the Efficacy and Safety of PARP Inhibitors in Advanced-Stage Epithelial Ovarian Cancer
Jiang Y, Zhao J, Zhang L, Tian S, Yang T, Wang L, et al.
Front Oncol
. 2020 Jul;
10:954.
PMID: 32719741
PARP inhibitors are a novel targeted anti-cancer drug and a large number of clinical studies on PARP inhibitors have been accomplished. This updated meta-analysis was conducted to evaluate the efficacy...